A Phase 2, Double-blind, Randomized, Placebo-controlled Milticenter Study to Evaluate Efficacy, Safety, and Tolerability of JBT-101 in Systemic Lupus Erythematosus
Research Grant
Administered By
Medicine, Rheumatology and Immunology
Awarded By
University of California - San Francisco
Start Date
January 1, 2017
End Date
October 31, 2019
Administered By
Medicine, Rheumatology and Immunology
Awarded By
University of California - San Francisco
Start Date
January 1, 2017
End Date
October 31, 2019